866-997-4948(US-Canada Toll Free)

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 114 Pages

This report studies the global market size of B-Cell Maturation Antigen(BCMA) Targeted Therapies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of B-Cell Maturation Antigen(BCMA) Targeted Therapies in these regions.
This research report categorizes the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the B-Cell Maturation Antigen(BCMA) Targeted Therapies market based on company, product type, application and key regions.

The various contributors involved in the value chain of B-Cell Maturation Antigen(BCMA) Targeted Therapies include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the B-Cell Maturation Antigen(BCMA) Targeted Therapies include
Transposagen Biopharmaceuticals
Sutro Biopharma
Malin Corporation
Eureka Therapeutics
firstVentury Equity
Five Prime Therapeutics
Credit Suisse Securities
Dana-Farber Cancer Institute
Deerfield Partners
Onyx Pharmaceuticals
Juno Therapeutics

Market Size Split by Type
Bispecific Antibodies
Antibody Drug Conjugates
Chimeric Antigen Receptor T-Cells
Market Size Split by Application
Liver Cancer
Respiratory Cancer
Brain Cancer
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global B-Cell Maturation Antigen(BCMA) Targeted Therapies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the B-Cell Maturation Antigen(BCMA) Targeted Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of B-Cell Maturation Antigen(BCMA) Targeted Therapies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of B-Cell Maturation Antigen(BCMA) Targeted Therapies are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of B-Cell Maturation Antigen(BCMA) Targeted Therapies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type
1.4.2 Bispecific Antibodies
1.4.3 Antibody Drug Conjugates
1.4.4 Chimeric Antigen Receptor T-Cells
1.5 Market by Application
1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Application
1.5.2 Liver Cancer
1.5.3 Respiratory Cancer
1.5.4 Brain Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size
2.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue 2016-2025
2.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales 2016-2025
2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Rate by Regions
2.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Regions
2.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Manufacturers
3.1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Manufacturers
3.1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Manufacturers
3.1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio (CR5 and HHI)
3.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Manufacturers
3.2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Manufacturers (2016-2018)
3.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Manufacturers (2016-2018)
3.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Price by Manufacturers
3.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Base Distribution, Product Types
3.4.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category
3.4.3 Date of International Manufacturers Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type
4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type
4.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Breakdown Data by Application

6 North America
6.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Countries
6.1.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries
6.1.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type
6.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application
6.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Company

7 Europe
7.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies by Countries
7.1.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries
7.1.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type
7.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application
7.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies by Company

8 Asia Pacific
8.1 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies by Countries
8.1.1 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries
8.1.2 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type
8.3 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application
8.4 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies by Company

9 Central & South America
9.1 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Countries
9.1.1 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries
9.1.2 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries
9.1.3 Brazil
9.2 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type
9.3 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application
9.4 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies by Company

10 Middle East and Africa
10.1 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies by Countries
10.1.1 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries
10.1.2 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type
10.3 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application
10.4 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies by Company

11 Company Profiles
11.1 Transposagen Biopharmaceuticals
11.1.1 Transposagen Biopharmaceuticals Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.1.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.1.5 Recent Development
11.2 Sutro Biopharma
11.2.1 Sutro Biopharma Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.2.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.2.5 Recent Development
11.3 Malin Corporation
11.3.1 Malin Corporation Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.3.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.3.5 Recent Development
11.4 Eureka Therapeutics
11.4.1 Eureka Therapeutics Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.4.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.4.5 Recent Development
11.5 firstVentury Equity
11.5.1 firstVentury Equity Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.5.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.5.5 Recent Development
11.6 Five Prime Therapeutics
11.6.1 Five Prime Therapeutics Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.6.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.6.5 Recent Development
11.7 Credit Suisse Securities
11.7.1 Credit Suisse Securities Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.7.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.7.5 Recent Development
11.8 Dana-Farber Cancer Institute
11.8.1 Dana-Farber Cancer Institute Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.8.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.8.5 Recent Development
11.9 Deerfield Partners
11.9.1 Deerfield Partners Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.9.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.9.5 Recent Development
11.10 Onyx Pharmaceuticals
11.10.1 Onyx Pharmaceuticals Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of B-Cell Maturation Antigen(BCMA) Targeted Therapies
11.10.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Description
11.10.5 Recent Development
11.11 Juno Therapeutics

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Material
13.1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Types (Product Category) in 2017
Figure Bispecific Antibodies Product Picture
Table Major Manufacturers of Bispecific Antibodies
Figure Antibody Drug Conjugates Product Picture
Table Major Manufacturers of Antibody Drug Conjugates
Figure Chimeric Antigen Receptor T-Cells Product Picture
Table Major Manufacturers of Chimeric Antigen Receptor T-Cells
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Liver Cancer
Figure Respiratory Cancer
Figure Brain Cancer
Figure Others
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Report Years Considered
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size 2016-2025 (Million US$)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales 2016-2025 (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Regions 2016-2025 (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Regions 2016-2025
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Regions 2016-2025
Figure 2017 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Regions
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Regions 2016-2025 (Million US$)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Regions 2016-2025
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Regions 2016-2025
Figure 2017 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Regions
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Manufacturers (2016-2018) (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Manufacturers (2016-2018)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Manufacturers in 2017
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Manufacturers (2016-2018) (Million US$)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Manufacturers (2016-2018)
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Value Share by Manufacturers in 2017
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers B-Cell Maturation Antigen(BCMA) Targeted Therapies Price (2016-2018) (USD/Unit)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category
Table Date of International Manufacturers Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type (2016-2025) (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Type (2016-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Type (2016-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Type in 2017
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type (2016-2025) (Million US$)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Type (2016-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type (2016-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type in 2017
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Price by Type 2013-2018 (USD/Unit)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Application (2016-2025) (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Share by Application (2016-2025)
Figure Global Sales B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2016-2025)
Figure Global Sales B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2016-2025)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate 2016-2025 (K Units)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2016-2025 (Million US$)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries (2016-2025) (K Units)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries (2016-2025)
Figure 2017 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries (2016-2025) (Million US$)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries (2016-2025)
Figure 2017 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries
Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type (2016-2025) (K Units)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Type (2016-2025)
Figure 2017 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Application (2016-2025) (K Units)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Application (2016-2025)
Figure 2017 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Company (2016-2018) (K Units)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company (2016-2018)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company in 2017
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate 2016-2025 (K Units)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2016-2025 (Million US$)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries (2016-2025) (K Units)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries (2016-2025)
Figure 2017 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries (2016-2025) (Million US$)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries
Figure Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (K Units)
Figure France B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure France B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (K Units)
Figure UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type (2016-2025) (K Units)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Type (2016-2025)
Figure 2017 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Application (2016-2025) (K Units)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Application (2016-2025)
Figure 2017 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Company (2016-2018) (K Units)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company (2016-2018)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company in 2017
Figure Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries (2016-2025) (K Units)
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Australia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Philippines B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Thailand B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Singapore B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type (2016-2025) (K Units)
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Application (2016-2025) (K Units)
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Company (2016-2018) (K Units)
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company (2016-2018)
Figure Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company in 2017
Figure Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries (2016-2025) (K Units)
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries (2016-2025) (Million US$)
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries
Figure Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type (2016-2025) (K Units)
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Application (2016-2025) (K Units)
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Company (2016-2018) (K Units)
Table Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company (2016-2018)
Figure Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company in 2017
Figure Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Countries
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Countries
Figure GCC Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure Egypt B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Growth Rate (2016-2025) (K Units)
Figure South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Type (2016-2025) (K Units)
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Application (2016-2025) (K Units)
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales by Company (2016-2018) (K Units)
Table Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company (2016-2018)
Figure Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Share by Company in 2017
Table Transposagen Biopharmaceuticals Company Details
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Transposagen Biopharmaceuticals Recent Development
Table Sutro Biopharma Company Details
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sutro Biopharma Recent Development
Table Malin Corporation Company Details
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Malin Corporation Recent Development
Table Eureka Therapeutics Company Details
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eureka Therapeutics Recent Development
Table firstVentury Equity Company Details
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table firstVentury Equity Recent Development
Table Five Prime Therapeutics Company Details
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Five Prime Therapeutics Recent Development
Table Credit Suisse Securities Company Details
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Credit Suisse Securities Recent Development
Table Dana-Farber Cancer Institute Company Details
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Dana-Farber Cancer Institute Recent Development
Table Deerfield Partners Company Details
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Deerfield Partners Recent Development
Table Onyx Pharmaceuticals Company Details
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Onyx Pharmaceuticals Recent Development
Table Juno Therapeutics Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Value Chain
Table Typical Suppliers of Key B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Material
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Customers List
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Channels
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *